Study Evaluating The Safety, Efficacy & Pharmacokinetics Of Temsirolimus(CCI-779) In Subjects With Advanced Renal Cell Carcinoma
Clinical trial NCT00494091 · COMPLETED
Trial details
- NCT number
- NCT00494091
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-02-01
- Primary completion
- 2011-05-01
- Enrollment
- 82
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.